Breaks Categories: Stock Spotlights

FridayNov 18, 2016 3:09 pm

NetworkNewsBreaks – eXp World Holdings, Inc.’s (EXPI) Real Estate Technology Primed for Gen Z

“Generation Z” is becoming a hot spot of focus in the real estate industry. The National Association of Realtors recently highlighted findings from a discussion among members of the Gen Z population in regards to their social media and shopping preferences, as well as future plans to become property owners. “Many polled Gen Z-ers said they will most likely work with a real estate agency, and that although they would search online they believe it is important to have professional guidance during the process. 8Z Real Estate (http://nnw.fm/9dNUK) put it perfectly: ‘There are 55 million of them, about 17% of…

Continue Reading

FridayNov 18, 2016 3:03 pm

NetworkNewsBreaks – Benefits of Social Media in Business Drive Agora Holdings, Inc.’s (AGHI) FRAME Technology

Agora Holdings (OTC: AGHI) is positioned to take advantage of the power of measurable social media campaigns and the increasing integration of social networks into marketing, communications and investor relations. “A report from the influential Pew Research Center on Social Media Usage: 2005 – 2015 (http://nnw.fm/6T7Bx) has discovered that ‘65% of adults now use social networking sites – a nearly tenfold jump in the past decade.’ … Social networking sites have created a parallel world that is beginning to rival the physical one, a trend that is only likely to grow. These changing dynamics are opening up novel approaches that…

Continue Reading

ThursdayNov 17, 2016 1:40 pm

NetworkNewsBreaks – Moleculin Biotech, Inc. (MBRX): Positive FDA Guidance could Allow Earlier Start to Next Clinical Trial

Moleculin Biotech (NASDAQ: MBRX) this morning said it has received verbal positive guidance from the FDA regarding the company’s planned IND submission, which could ultimately enable the company to start its next clinical trial earlier than expected. "This new positive guidance removes a major question mark and allows us to create a tighter timeline for the estimated beginning of our next clinical trial. To be clear, we still can't rule out the possibility of a delay in the timeline, but with the knowledge that the FDA is encouraging us to simply incorporate by reference the prior developer's IND, we believe…

Continue Reading

ThursdayNov 17, 2016 11:52 am

NetworkNewsBreaks – AcelRx Pharmaceuticals, Inc. (ACRX) to Present ARX-04 SAP303 Study Results at Annual ASRA Pain Medicine Meeting

AcelRx Pharmaceuticals (NASDAQ: ACRX), focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, this morning announced its upcoming presentation of the complete results from the phase 3 SAP303 study of ARX-04. The presentation will take place at the ongoing 15th Annual Pain Medicine Meeting of the American Society of Regional Anesthesia and Pain Medicine (ASRA). To view the full press release, visit: http://nnw.fm/3cX1B About AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company's…

Continue Reading

ThursdayNov 17, 2016 9:00 am

NetworkNewsBreaks – Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) Disposable Vaporizers Highlighted on Leafly.com

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) was featured in an article on Leafly titled ‘Product Review: The Wildflower Disposable Vape Pen’ authored by Darren Harris. The article features Wildflower's hybrid strain THC disposable vape pen, Eclipse. Consumers benefit from the discreetness of the pen while enjoying a powerful and smooth draw each time. The Eclipse pen is disposable and requires no charging, appealing to first time users and those who need a light and pleasant boost throughout the day. The article also features Wildflower's non-THC disposable pens, Aches and Immunity, which include not only CBD, but a unique blend of…

Continue Reading

WednesdayNov 16, 2016 12:49 pm

Amyris, Inc. (AMRS) Collaboration Reaches “Key Milestone” in Oncology Drug Development

Amyris (NASDAQ: AMRS) shares are ticking higher after the industrial bioscience company said its collaboration with “one of the world’s leading” pharmaceutical companies has resulted in the creation of a “robust, sensitive activity assay for an oncology target in a live yeast strain.” This high-throughput assay enables screening for chemical diversity found in nature using Amyris’s proprietary µPharm™ platform, with the potential to provide previously inaccessible molecule targets. The µPharm platform combines two powerful technologies that Amyris said can significantly accelerate and reduce the cost of new drug discovery. To view the full press release, visit: http://nnw.fm/9LkVH About Amyris Amyris…

Continue Reading

TuesdayNov 15, 2016 1:09 pm

Marathon Patent Group, Inc. (MARA) Subsidiary Inks Licensing Deal with the University of Cincinnati; Shares Lower

3D Nanocolor Corporation, a subsidiary of Marathon Patent Group (NASDAQ: MARA), has entered into an exclusive license agreement with the University of Cincinnati covering the company’s patent-pending applications based on 3D Nanocolor's electrokinetic (EK) technology. 3D Nanocolor will showcase a prototype of the technology early next year. "The recent addition of two highly capable and accomplished technologists with specific experience in our field of technology, combined with our prototype of our technology being showcased to executives of a leading European automobile manufacturer in early 2017, gives us cause for optimism. We are working diligently and looking forward to the opportunity…

Continue Reading

TuesdayNov 15, 2016 11:33 am

Fusion Telecommunications (FSNN) Trades Higher on Apptix Acquisition, Q3 Performance, New Credit Facility

Shares of Fusion Telecommunications (NASDAQ: FSNN) are 10% higher after the company announced its acquisition of Virginia-based cloud services provider Apptix, Inc. for $28 million, as well as reported third-quarter revenue of $29.5 million and a $70 million credit facility. Fusion attributes the 20% YoY increase in consolidated revenue to revenue growth of 27% from its Business Services segment. To view the full press release, visit: http://nnw.fm/0zz9C About Fusion Fusion, a leading provider of integrated cloud solutions to small, medium and large businesses, is the industry's single source for the cloud. Fusion's advanced, proprietary cloud service platform enables the integration…

Continue Reading

MondayNov 14, 2016 12:03 pm

FDA Response Triggers Dynavax Technologies (DVAX) Sell-off

Dynavax Technologies (NASDAQ: DVAX) is down more than 60% mid-morning after the company said it received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for its HEPLISAV-B™ vaccine against hepatitis B infection. The CRL signals the FDA’s completed a review of an application and stands as a request for additional information for review and approval. Dynavax said it expects a Class 2 designation for a resubmission of the BLA, which would result in a target review period of six months. To view the full press release, visit: http://nnw.fm/9mS6x About Dynavax Dynavax, a clinical-stage biopharmaceutical…

Continue Reading

MondayNov 14, 2016 12:00 pm

National Waste Management Holdings, Inc. (NWMH) is Active Participant in Florida’s Statewide Recycling Initiative

The State of Florida is working toward a statewide recycling goal of 75% by the year 2020. The journey to such a high bar is a lengthy one. While the state’s recycling rate increased by 4% between 2012 and 2013, the amount of solid waste has also increased, from just under 28 million tons to over 30 million. Florida’s Department of Environmental Protection believes that more commercial recycling would help reach its goal of 75%, and National Waste Management Holdings, Inc. (OTC: NWMH) is addressing the challenge head on. Reporting third-quarter revenue growth of 269%, National Waste employs a strategic…

Continue Reading